EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 350 filers reported holding EXELIXIS INC in Q4 2020. The put-call ratio across all filers is 2.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,707,128 | +14.3% | 123,896 | 0.0% | 0.22% | +19.0% |
Q2 2023 | $2,367,653 | -1.5% | 123,896 | 0.0% | 0.19% | -4.5% |
Q1 2023 | $2,404,821 | +72.1% | 123,896 | +42.2% | 0.20% | +69.2% |
Q4 2022 | $1,397,357 | -10.3% | 87,117 | -12.3% | 0.12% | -11.4% |
Q3 2022 | $1,558,000 | -24.7% | 99,343 | 0.0% | 0.13% | -18.5% |
Q2 2022 | $2,068,000 | -8.2% | 99,343 | 0.0% | 0.16% | +18.2% |
Q1 2022 | $2,252,000 | +24.0% | 99,343 | 0.0% | 0.14% | +41.2% |
Q4 2021 | $1,816,000 | -13.5% | 99,343 | 0.0% | 0.10% | -19.2% |
Q3 2021 | $2,100,000 | +16.0% | 99,343 | 0.0% | 0.12% | +17.6% |
Q2 2021 | $1,810,000 | -16.6% | 99,343 | +3.4% | 0.10% | -20.3% |
Q1 2021 | $2,171,000 | +12.5% | 96,115 | +0.0% | 0.13% | +9.4% |
Q4 2020 | $1,929,000 | – | 96,090 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |